EVHEvolent Health, Inc.
$4.80-41% 1Y
$4.80
$2.1752 weeks$7.81
Is the price fair?
What EVH's price assumes
Evolent Health, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.29× revenue.
0.29
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.59
Price / book · as of 2026-Q2
- EV / sales
- 0.70
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.59
- EV / EBIToperating margin −20%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 0.70
- Market capitalisation113.1 million shares, counted Aug 1, 2026
- $542M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Health Information Services
Ranks #17 of 18 by RyuScore